Paula Molero-Glez

7PUBLICATIONS
50CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 07, 2026
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

|Aug 06, 2026
Antibody-Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors.

|Jan 16, 2026
Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab.

Miguel F Sanmamed, Carlos E de Andrea, David Ruiz-Guillamon

|Sep 04, 2025
The Dark Side of NK Cells in Cancer Immunotherapy.

Felipe Galvez-Cancino, Maria Armero, David R Withers

|Nov 12, 2024
Targeting T-Cell Costimulation to the Surface of Tumor Cells.

Iñaki Eguren-Santamaría, Miguel F Sanmamed, Paula Molero-Glez

|Aug 09, 2024
CD137 (4-1BB) and T-Lymphocyte Exhaustion.

Paula Molero-Glez, Arantza Azpilikueta, Laura Mosteo

Pageof 2

Frequent Collaborators

7 joint publications

Ignacio Melero

3 joint publications

Angie Molina

3 joint publications

Arantza Azpilikueta

3 joint publications

Belen Palencia